Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.95 |
| ▸ | LMNA | P02545 | 1/20 | 0.95 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vitamin K3H2 SCHEMBL29525544 | 0.98 | HTT (1.00) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL297164 | 0.98 | HTT (1.00) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL27560223 | 0.90 | HTT (0.78) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL987810 | 0.89 | HTT (0.75) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL515182 | 0.88 | HTT (0.81) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL5075246 | 0.88 | HTT (0.81) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL516200 | 0.88 | HTT (0.81) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL515420 | 0.88 | HTT (0.81) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL28664356 | 0.88 | HTT (0.81) | HTTLMNAPKMMAPTKDM4E | |
| Vitamin K3H2 SCHEMBL21437091 | 0.83 | HTT (0.72) | HTTLMNAPKMMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020044968-A1 | High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion | GENERAL MILLS, INC. | 2002-04-18 | — | — | US | claimed |
| WO-2016118787-A1 | ENGINEERED RECEPTOR/LIGAND SYSTEM FOR DELIVERY OF THERAPEUTIC AGENTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-07-28 | — | — | WO | disclosed |
| US-9272038-B2 | Wound care formulation | INNOVATION ULSTER LIMITED (GB) | 2016-03-01 | — | — | US | disclosed |
| US-20100286205-A1 | WOUND CARE FORMULATION | JENARRON THERAPEUTICS LIMITED (GB) | 2010-11-11 | — | — | US | disclosed |
| US-6159931-A | Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells | THE OHIO STATE UNIVERSITY (US) | 2000-12-12 | — | — | US | disclosed |
| WO-1999016425-A1 | LIPID-MODIFIED INSULIN INCORPORATED LIPOSOMES FOR SELECTIVELY DELIVERING CYTOTOXIC AGENTS TO HEPATOMA CELLS | THE OHIO STATE UNIVERSITY (US) | 1999-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286205-A1 | WOUND CARE FORMULATION | SORD, DAD1, RAP1A | HTT 4268/4885LMNA 3301/4885PKM 1277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.